SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007438
Filing Date
2022-05-05
Accepted
2022-05-05 16:50:45
Documents
69
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx-20220331x10q.htm   iXBRL 10-Q 1596856
2 EX-10.1 ptgx-20220331xex10d1.htm EX-10.1 36215
3 EX-31.1 ptgx-20220331xex31d1.htm EX-31.1 10119
4 EX-31.2 ptgx-20220331xex31d2.htm EX-31.2 10143
5 EX-32.1 ptgx-20220331xex32d1.htm EX-32.1 9500
6 GRAPHIC ptgx-20220331x10q007.jpg GRAPHIC 91932
7 GRAPHIC ptgx-20220331xex10d1001.jpg GRAPHIC 18721
  Complete submission text file 0001558370-22-007438.txt   7286822

Data Files

Seq Description Document Type Size
8 EX-101.SCH ptgx-20220331.xsd EX-101.SCH 53708
9 EX-101.CAL ptgx-20220331_cal.xml EX-101.CAL 47924
10 EX-101.DEF ptgx-20220331_def.xml EX-101.DEF 228038
11 EX-101.LAB ptgx-20220331_lab.xml EX-101.LAB 413995
12 EX-101.PRE ptgx-20220331_pre.xml EX-101.PRE 352773
63 EXTRACTED XBRL INSTANCE DOCUMENT ptgx-20220331x10q_htm.xml XML 1278701
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 22897288
SIC: 2834 Pharmaceutical Preparations